Effects of peripheral blood CD34 + cells count on the collection timing and results of peripheral blood stem cells
10.3760/cma.j.cn115355-20200119-00027
- VernacularTitle:外周血CD34 +细胞计数对外周血干细胞采集时机选择及结果的影响
- Author:
Min BAI
1
;
Lieyang WANG
;
Zhenhua LI
;
Jiangtao WANG
;
Tao GUAN
;
Xiaolan LIU
;
Zong ZHANG
;
Jin ZHAO
;
Liping SU
Author Information
1. 山西省肿瘤医院血液科，太原 030013
- Keywords:
Peripheral blood cell;
CD34 + cells;
Stem cell mobilization;
Stem cell collection
- From:
Cancer Research and Clinic
2021;33(9):681-684
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the variation trend of peripheral blood CD34 + cells during the hematopoietic stem cell mobilization and its influence on the collection timing and results. Methods:The clinical data of 62 patients with hematologic diseases undergoing autologous peripheral blood hematopoietic stem cell mobilization from April 2012 to March 2017 in Shanxi Provincial Cancer Hospital were analyzed. Mobilization regimen used chemotherapy combined with granulocyte colony-stimulating factor (G-CSF) to monitor the number of white blood cells (WBC), mononuclear cells (MNC), CD34 + cells in peripheral blood and apheresis concentrates, and the correlation with CD34 + cells was analyzed. Furthermore, the receiver operating characteristic (ROC) curve was used to establish the threshold to start apheresis. Results:MNC (5.66±1.11)×10 8/kg and CD34 + cell count (2.15±1.20)×10 6/kg were obtained in 62 patients who received 136 times collection in total. The peak of peripheral blood CD34 + cells count appeared at day 4-5 after the treatment of G-CSF, and then it went down. CD34 + cell count in the product was correlated with the peripheral blood CD34 + cell count collected on the day ( r = 0.879, P < 0.01), and it was also correlated with the peripheral blood WBC and MNC collected on the day as well as MNC count in the product (all P < 0.05). Furthermore, the ROC curve analysis demonstrated that peripheral blood CD34 + cells count > 23/μl was the optimal threshold for stem cell collection on the day, 85.2% of patients reaching up to the threshold could be successfully collected at one time. Conclusions:The variation trend of peripheral blood CD34 + cell count can guide the best time of stem cell collection in clinic. Peripheral blood CD34 + cell count is the reliable index to predict CD34 + cells count in the products. Peripheral blood CD34 + cells count > 23/μl could be used as the collection threshold.
